Literature DB >> 27295125

Isomer-Specific Distribution of Perfluoroalkyl Substances in Blood.

Hangbiao Jin1,2, Yifeng Zhang1,2, Weiwei Jiang3, Lingyan Zhu1, Jonathan W Martin2.   

Abstract

Perfluoroalkyl substances (PFASs) such as perfluorohexanesulfonate (PFHxS), perfluorooctanoate (PFOA), perfluorooctanesulfonate (PFOS) and PFOS-precursors are routinely measured in human plasma and serum, but their relative abundance in the blood cell fraction has not been carefully examined, particularly at the isomer-specific level. Human plasma and whole blood were collected and partitioning behaviors of PFASs and their isomers between plasma and blood cells were investigated. In human samples, mass fraction in plasma (Fp) for PFASs increased among perfluoroalkyl carboxylates as the carbon chain length increased from C6 (mean 0.24) to C11 (0.87), indicating preference for the plasma fraction with increasing chain length. However, among perfluoroalkyl sulfonates, PFHxS (mean 0.87) had a slightly higher Fp than PFOS (0.85). In vitro assays with spiked Sprague-Dawley rat blood were also conducted, and the results showed that PFOS-precursors had lower Fp values than perfluoroalkyl acids, with perfluoroctanesulfonamide having the lowest Fp (mean 0.24). Consistently, linear isomers of PFOS and PFOS-precursors had lower mean Fp than their corresponding total branched isomers. Multiplying by a factor of 2 is not a reasonable method to convert from whole blood to plasma PFAS concentrations, and current ratios could be used as more accurate conversion factors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27295125     DOI: 10.1021/acs.est.6b01698

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  3 in total

1.  Physico-chemical properties and gestational diabetes predict transplacental transfer and partitioning of perfluoroalkyl substances.

Authors:  Berrak Eryasa; Philippe Grandjean; Flemming Nielsen; Damaskini Valvi; Denis Zmirou-Navier; Elsie Sunderland; Pal Weihe; Youssef Oulhote
Journal:  Environ Int       Date:  2019-06-11       Impact factor: 9.621

2.  The influences of perfluoroalkyl substances on the rheumatoid arthritis clinic.

Authors:  Yun Zhao; Hangbiao Jin; Jianli Qu; Sunzhao Zhang; Shilei Hu; Jing Xue; Meirong Zhao
Journal:  BMC Immunol       Date:  2022-03-04       Impact factor: 3.615

3.  Analysis of Specific Perfluorohexane Sulfonate Isomers by Liquid Chromatography-Tandem Mass Spectrometry: Method Development and Application in Source Apportionment.

Authors:  Liping Yang; Xin Chen; Lingyan Zhu; Yixin Wang; Guoqiang Shan
Journal:  J Anal Methods Chem       Date:  2022-09-22       Impact factor: 2.594

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.